Improving cervical cancer screening and treatment for women with HIV in Kenya
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
This program is working to increase cervical cancer screening and make sure women living with HIV in Kenya get connected quickly to treatment when needed.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11172252 on NIH RePORTER |
What this research studies
From my point of view, the team partners with Kenyan clinics and hospitals to make screening more available and to speed up follow-up care for women with HIV. They train local health workers, engage communities and health authorities, and test practical ways to deliver screening and referrals in real clinics. The center runs linked research projects and builds local research capacity so solutions can be sustained and spread. They will collect program data to see which approaches help the most and refine care pathways accordingly.
Who could benefit from this research
Good fit: Women living with HIV in Kenya who are eligible for cervical cancer screening and who attend participating clinics are the ideal candidates.
Not a fit: People without HIV, those outside Kenya or outside participating clinics, and individuals whose cancer is already very advanced may not directly benefit from this program.
Why it matters
Potential benefit: If successful, more women living with HIV could get screened earlier and receive timely treatment, lowering preventable illness and deaths from cervical cancer.
How similar studies have performed: Cervical cancer screening and early treatment are proven to save lives, but applying these programs consistently in sub-Saharan Africa has been uneven, so this work focuses on making proven approaches work better in real-world settings.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Chung, Michael Hoonbae — Emory University
- Study coordinator: Chung, Michael Hoonbae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.